• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Imvax Submits Glioblastoma Data To FDA Showing 6-Month Survival

    PHARMIWEB

    Imvax to Present Safety Data on IGV-001 at 2024 SNO Annual Meeting

    BUSINESSWIRE

    Imvax Completes IGV-001 Phase 2b Enrollment, Funding Round

    BUSINESSWIRE

    Imvax Announces Publication in Journal for ImmunoTherapy of Cancer Showing IGV-001 Can Induce Clinically Relevant Anti-Cancer Immune Responses in Glioblastoma via Immunogenic Cell Death

    BUSINESSWIRE

    Imvax Presents New Data at AACR 2023 Supporting the Mechanism of Action

    BUSINESSWIRE

    Imvax Announces First Patient Dosed in Ph 2b Trial of IGV-001 for Glioblastoma

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.